Squarepoint’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,488
| Closed | -$15.5K | – | 5032 |
|
|
2024
Q3 | $15.5K | Sell |
1,488
-3,634
| -71% | -$60.4K | ﹤0.01% | 4035 |
|
|
2024
Q2 | $101K | Buy |
+5,122
| New | +$103K | ﹤0.01% | 3799 |
|
|
2024
Q1 | – | Sell |
-42,888
| Closed | -$1.18M | – | 4048 |
|
|
2023
Q4 | $1.18M | Buy |
42,888
+37,103
| +641% | +$2.26M | ﹤0.01% | 2407 |
|
|
2023
Q3 | $352K | Sell |
5,785
-3,318
| -36% | -$233K | ﹤0.01% | 3050 |
|
|
2023
Q2 | $599K | Sell |
9,103
-21,300
| -70% | -$1.56M | ﹤0.01% | 2505 |
|
|
2023
Q1 | $1.93M | Sell |
30,403
-16,769
| -36% | -$1.92M | 0.01% | 1435 |
|
|
2022
Q4 | $6.53M | Buy |
47,172
+24,778
| +111% | +$3.49M | 0.03% | 695 |
|
|
2022
Q3 | $2.83M | Buy |
22,394
+21,048
| +1,564% | +$2.38M | 0.01% | 1085 |
|
|
2022
Q2 | $111K | Buy |
+1,346
| New | +$104K | ﹤0.01% | 2604 |
|
|
2021
Q3 | – | Sell |
-3,156
| Closed | -$1.31M | – | 2928 |
|
|
2021
Q2 | $1.31M | Sell |
3,156
-7,284
| -70% | -$2.89M | 0.01% | 1443 |
|
|
2021
Q1 | $4.08M | Buy |
10,440
+1,240
| +13% | +$611K | 0.02% | 726 |
|
|
2020
Q4 | $5.16M | Buy |
9,200
+1,474
| +19% | +$934K | 0.04% | 473 |
|
|
2020
Q3 | $5.4M | Buy |
7,726
+5,199
| +206% | +$4.05M | 0.07% | 324 |
|
|
2020
Q2 | $2M | Buy |
+2,527
| New | +$1.91M | 0.03% | 632 |
|
|
2020
Q1 | – | Sell |
-11,671
| Closed | -$13.3M | – | 1896 |
|
|
2019
Q4 | $13.3M | Buy |
+11,671
| New | +$12.7M | 0.08% | 223 |
|
|
2019
Q1 | – | Sell |
-2,440
| Closed | -$3.13M | – | 2143 |
|
|
2018
Q4 | $3.13M | Buy |
+2,440
| New | +$3.74M | 0.04% | 542 |
|
|
2018
Q3 | – | Sell |
-8,273
| Closed | -$16.8M | – | 1988 |
|
|
2018
Q2 | $16.8M | Buy |
8,273
+5,972
| +260% | +$13.6M | 0.22% | 111 |
|
|
2018
Q1 | $5.09M | Buy |
+2,301
| New | +$5.85M | 0.08% | 303 |
|
|
2017
Q3 | – | Sell |
-679
| Closed | -$924K | – | 1618 |
|
|
2017
Q2 | $924K | Sell |
679
-175
| -20% | -$211K | 0.02% | 751 |
|
|
2017
Q1 | $1M | Buy |
+854
| New | +$871K | 0.03% | 606 |
|
|
2016
Q4 | – | Sell |
-772
| Closed | -$678K | – | 1767 |
|
|
2016
Q3 | $678K | Buy |
+772
| New | +$559K | 0.05% | 463 |
|
|
2016
Q2 | – | Sell |
-1,312
| Closed | -$723K | – | 1108 |
|
|
2016
Q1 | $723K | Buy |
+1,312
| New | +$806K | 0.06% | 475 |
|
Other funds holding BLUE
APM
LPC
PHS
Squarepoint's BLUE Position: Q4 2024 in Review
Squarepoint sold out of bluebird bio (BLUE) in Q4 2024, closing a stake of 1,488 shares — an estimated $15.5K sold.
Squarepoint first reported a position in BLUE in Q1 2016 and held it in 22 quarters. The position peaked at $16.8M in Q2 2018. 83 funds tracked by Wall St. Rank hold BLUE as of Q4 2024.
- Squarepoint reported no remaining bluebird bio position as of Q4 2024 after selling out during the quarter.
- Squarepoint sold 1,488 bluebird bio shares in Q4 2024, an estimated $15.5K.
- Squarepoint first reported a position in bluebird bio in Q1 2016 and held it in 22 quarters.
- Squarepoint's bluebird bio position peaked at $16.8M in Q2 2018.
- 83 funds tracked by Wall St. Rank held bluebird bio as of Q4 2024.
Based on Squarepoint's 13F filing for Q4 2024, filed 14 Feb 2025.